BioCentury | May 27, 2013
Finance

Demand disequilibrium

BioCentury's 11th annual European Iceberg survey sees funding demand continue to fall for a shrinking number of public clinical-stage biotechs in Europe, while the capital demanded by the growing cadre of venture biotechs continues to...
BC Week In Review | Dec 3, 2012
Company News

Alterna, Moberg Derma deal

Moberg acquired its U.S. distributor Alterna for about SEK133 million ($20 million) in a cash and stock deal. Moberg issued Alterna SEK33 million ($4.9 million), or 825,625 shares, in Moberg stock and paid about SEK100...
BioCentury | Mar 19, 2012
Finance

Highlights of weekly biotech stock moves

Active Biotech AB (SSE:ACTI) gained SEK9.70 (24%) to SEK49.40 on Thursday after partner Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) said it plans to submit an MAA to EMA in 2H12 for laquinimod in multiple sclerosis (MS)....
BC Extra | May 21, 2011
Financial News

Moberg raises $11.6 million in IPO

Moberg Derma AB (Stockholm, Sweden) raised SEK74 million ($11.6 million) through the sale of 2.6 million shares at SEK29 in an IPO on NASDAQ OMX Stockholm. The price values the company at SEK263.3 million ($41.3...
BioCentury | May 9, 2011
Finance

IPO watch

IPO watch Topical dermatology company Moberg Derma AB refiled for an IPO to raise up to SEK74 million ($12.3 million). This time it looks like the offering might get done. Last December, Moberg withdrew a...
BC Extra | May 3, 2011
Financial News

Moberg refiles for IPO

Moberg Derma AB (Stockholm, Sweden) refiled to raise up to SEK74 million ($12.3 million) through the sale of up to 2.6 million shares at SEK29 in an IPO on NASDAQ OMX Stockholm. If the shares...
BioCentury | Dec 20, 2010
Finance

IPO Watch

IPO watch Ventrus Biosciences Inc. (NASDAQ:VTUS) got its IPO done Friday at the bottom of its range, but shares managed to trade up $0.30 to $6.30 on the day. The specialty GI play sold a...
BC Extra | Dec 14, 2010
Financial News

Moberg Derma pulls IPO

Moberg Derma AB (Stockholm, Sweden) withdrew its IPO after determining that demand from investors was not sufficient to ensure a successful listing. The company filed in November to raise SEK140 million ($20.3 million) through the...
BioCentury | Nov 22, 2010
Finance

IPO Watch

IPO watch Neurology and drug delivery play AcelRx Pharmaceuticals Inc. filed to raise up to $86.3 million. AcelRx's lead candidate is the Sufentanil NanoTab PCA System ( ARX-01 ), a sublingual formulation of the synthetic opioid...
BC Extra | Nov 16, 2010
Financial News

Moberg files for IPO

Moberg Derma AB (Stockholm, Sweden) filed to raise SEK140 million ($20.3 million) through the sale of 3.1-3.8 million shares at SEK37-SEK45 in an IPO on NASDAQ OMX Stockholm. The price range would value the company...
Items per page:
1 - 10 of 10